ID   TIG-114
AC   CVCL_3199
SY   TIG114; Tokyo Institute of Gerontology-114
DR   JCRB; JCRB0534
DR   JCRB; NIHS0207
DR   Wikidata; Q54972437
RX   PubMed=7556460;
RX   PubMed=15900046;
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Doubling time: 2.5-3.6 days (Note=Lot 12012010), ~56 hours (Note=Lot 10112012) (JCRB=JCRB0534).
CC   Discontinued: JCRB; NIHS0207; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
RX   PubMed=7556460; DOI=10.1006/excr.1995.1342;
RA   Kondo H., Yonezawa Y.;
RT   "Fetal-adult phenotype transition, in terms of the serum dependency
RT   and growth factor requirements, of human skin fibroblast migration.";
RL   Exp. Cell Res. 220:501-504(1995).
//
RX   PubMed=15900046; DOI=10.1093/jnci/dji133;
RA   Mashima T., Oh-hara T., Sato S., Mochizuki M., Sugimoto Y.,
RA   Yamazaki K., Hamada J.-i., Tada M., Moriuchi T., Ishikawa Y., Kato Y.,
RA   Tomoda H., Yamori T., Tsuruo T.;
RT   "p53-defective tumors with a functional apoptosome-mediated pathway: a
RT   new therapeutic target.";
RL   J. Natl. Cancer Inst. 97:765-777(2005).
//
RX   PubMed=19956543; DOI=10.1371/journal.pone.0008067; PMCID=PMC2780725;
RA   Takahashi K., Narita M., Yokura M., Ichisaka T., Yamanaka S.;
RT   "Human induced pluripotent stem cells on autologous feeders.";
RL   PLoS ONE 4:e8067.1-e8067.6(2009).
//